Genetixcare Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -28.65%
- Ebitda 26.74%
- Net Worth -99.00%
- Total Assets -8.06%
About Genetixcare Lifesciences
Genetixcare Lifesciences Limited (GLL) is a Public Limited Indian Non-Government Company incorporated in India on 15 July 2014 and has a history of Ten years and seven months. Its registered office is in Kozhikode, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Savitha Somakumar, Ridhul Raveendran, and Sheena Ayiraveettil serve as directors at the Company.
Company Details
-
Location
Kozhikode, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232KL2014PLC036905
-
Company No.
036905
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
15 Jul 2014
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Genetixcare Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savitha Somakumar
|
Director | 15-Jul-2014 | Current |
|
Ridhul Raveendran
|
Whole-Time Director | 15-Jul-2014 | Current |
|
Sheena Ayiraveettil
|
Director | 15-Jul-2014 | Current |
Financial Performance of Genetixcare Lifesciences.
Genetixcare Lifesciences Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28.65% decrease in profit. The company's net worth observed a substantial decline by a decrease of 99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genetixcare Lifesciences?
In 2019, Genetixcare Lifesciences had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Uniwave Healthcare LlpSheena Ayiraveettil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genetixcare Lifesciences?
Unlock and access historical data on people associated with Genetixcare Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genetixcare Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genetixcare Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
